Leprosy.
Lockwood
Diana
D
London School of Hygiene & Topical Medicine and The Hospital for Tropical Diseases, London, UK.
D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D009166:Mycobacterium leprae / Q000276:immunology; D012293:Rifampin / Q000627:therapeutic use
D001500:BCG Vaccine; D001428:Bacterial Vaccines; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin